MCK vs SYBX · P/E 20, rev $403.43B vs P/E 5.5, $14.2M cap
McKesson Corporation (MCK) versus Synlogic Inc (SYBX) — a side-by-side from cached financials, not a winner call.
McKesson Corporation (MCK) is a medical distribution company listed on NYSE.
Synlogic Inc (SYBX) is a biotechnology company listed on US.
Latest reported MCK revenue for 2026-03-31 was $403.43B. Net income was $4.76B. Revenue was up 12.4% from 2025-03-31 to 2026-03-31. MCK currently screens at market cap $91.30B and trailing P/E 20.3.
Latest reported SYBX revenue for 2026-06-30 was $0. Net income was -$543.0K. SYBX currently screens at market cap $14.2M and trailing P/E 5.5.
MCK currently screens at market cap $91.30B and trailing P/E 20.3. SYBX currently screens at market cap $14.2M and trailing P/E 5.5.
Not investment advice. Open the MCK and SYBX stock pages for the full models.
Not investment advice.